Table 2.
Hereditary cancer syndromes.
Hereditary cancer syndrome | Responsible gene(s) | Inheritance | Lifetime risk of gastric cancer | Other malignancies |
---|---|---|---|---|
Lynch syndrome (LS) | MLH1, MSH2, MSH6, PMS2, EPCAM | AD | 1–13% | Uterus, ovary, hepatobiliary, urological, pancreas, brain, small bowel (3–25) |
Li-Fraumeni syndrome (LFS) | TP53 | AD | <3% | Sarcoma, breast, brain, adrenal cortical (2, 6) |
Peutz-Jeghers syndrome (PJS) | STK11 | AD | 29% | Breast, pancreas, small bowel, lung, ovary, testis, cervix (27) |
Familial adenomatous polyposis (FAP) | APC | AD | ~0.6% | Thyroid, duodenum, small bowel, brain (28) |
Juvenile polyposis syndrome (JPS) | SMAD4, BMPR1A | AD | 30% in those with SMAD4 mutations | Small bowel, pancreas (2, 9, 30) |
MUTYH-associated adenomatous polyposis (MAP) | MUTYH | AR | No statistically significant data available | Thyroid, duodenum (1, 6) |
Hereditary breast and ovarian cancer syndrome (HBOC) | BRCA1, BRCA2 | AD | Undefined | Breast, ovary, pancreas, melanoma (31–33) |
AD, autosomal dominant; AR, autosomal recessive.